Clinical Trials Logo
  1. Home
  2. Atrial Fibrillation Recurrent
  3. NCT06202209

The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation

Atrial Fibrillation Recurrent Clinical Trial

Official title:
The Impact of Autonomic Function on Recurrence Following Circumferential Pulmonary Vein Ablation for Atrial Fibrillation

Clinical Trial Summary

This is a prospective and observational study. The investigator speculated that the use of DC in patients with paroxysmal AF can serve as a predictor for early and late AF recurrence following CPVI.

Clinical Trial Description

Atrial fibrillation (AF), also known as atrial flutter, is one of the most common cardiac arrhythmias and poses a serious threat to patients' health and well-being. The mechanism of AF is complex, with the autonomic nervous system playing a crucial role in its initiation and maintenance. Currently, medication and ablation are the main treatment methods to reduce AF episodes, but the efficacy of drug therapy is limited, and recurrence after ablation still exists. Recent studies have found that changes in autonomic nervous system activity are one of the key factors contributing to AF recurrence after ablation. Therefore, by objectively assessing changes in autonomic nervous system activity, it is expected to improve the success rate of AF ablation and provide a potential cure for AF, with significant social and economic value. Studies have found that pulmonary vein isolation (PVI) ablation is the mainstream method for AF ablation, and it affects the autonomic nervous system function. Patients who show significant changes in autonomic nervous system function after AF ablation have higher success rates. Additionally, early-onset atrial arrhythmias are closely related to long-term AF recurrence after ablation. However, the mechanisms underlying early recurrence still require further investigation. Our research team has conducted in-depth studies on the regulation of autonomic nervous system function in the heart and non-invasive assessment techniques, achieving breakthrough progress. The left atrial ganglion plays a crucial role in the initiation and maintenance of AF, and ablating the ganglion can improve the success rate of AF ablation. Non-invasive assessment techniques such as heart rate deceleration can quantitatively evaluate changes in vagal nerve activity in the heart, which can be used to predict the efficacy of autonomic ganglion intervention therapy. Based on the above research, our research team hypothesizes that precise and quantitative assessment of autonomic nervous system function using heart rate deceleration can predict AF recurrence after PVI ablation. To validate this hypothesis, we plan to conduct a prospective observational study, recruiting patients with paroxysmal AF, assessing changes in autonomic nervous system function, monitoring early-onset atrial arrhythmias and AF recurrence, and providing theoretical support for the screening and intervention of high-risk recurrence patients, laying a foundation for clinical application. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06202209
Study type Observational
Source China National Center for Cardiovascular Diseases
Contact yan Yao, PhD
Phone 13901121319
Email ianyao@263.net.cn
Status Recruiting
Phase
Start date September 13, 2023
Completion date October 30, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Not yet recruiting NCT04780438 - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Early Phase 1
Not yet recruiting NCT06098989 - A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study) N/A
Recruiting NCT05781282 - Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation Phase 4
Terminated NCT04704050 - Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Phase 4
Recruiting NCT04968678 - Exploring P-Wave Duration in Arrhythmia Recurrence in Patients Undergoing AF Ablation
Completed NCT04964440 - Redo AF Sub Study (of the Pure EP 2.0 Main Study)
Not yet recruiting NCT06204640 - SPironolactONe for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Phase 3
Recruiting NCT06253000 - Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium N/A
Not yet recruiting NCT06199180 - Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF N/A
Recruiting NCT03075930 - Atrial Fibrillation Ablation Registry
Recruiting NCT05528419 - Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation Phase 4
Not yet recruiting NCT06130358 - Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults N/A
Completed NCT05486364 - DIGITal mOnitoring afTer Af abLation N/A
Recruiting NCT05159180 - Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
Active, not recruiting NCT06111443 - Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation Phase 2/Phase 3